🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Deciphering treatment resistance in metastatic colorectal cancer: roles of drug transports, EGFR mutations, and HGF/c-MET signaling

Frontiers in Pharmacology(2024)10.3389/fphar.2023.1340401Source: DataRank Database

Deciphering treatment resistance in metastatic colorectal cancer: roles of drug transports, EGFR mutations, and HGF/c-MET signaling is a research paper published in Frontiers in Pharmacology (2024). On theSindex it has a DataRank of 0. It has been cited 23 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access23 citations

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: goldTopics (12)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Yang Xie ORCID,Wěi Li ORCID,Najah Albadari

Live enrichment

PubMed:38269272 PMC:PMC10806212

NCI NIH HHS

Grant: R01 CA240447

NCI NIH HHS

Grant: R01 CA148706

National Institutes of Health

Grant: 5R01CA240447-04

Dual inhibition of MDM2 and XIAP as a therapeutic strategy in cancer

National Institutes of Health

Grant: 5R01CA148706-10

Targeting the colchicine site in tubulin for advanced melanoma

goldLicense: cc-by

publisherhttps://www.frontiersin.org/articles/10.3389/fphar.2023.1340401/pdf?isPublishedV2=False

publisherhttps://www.frontiersin.org/articles/10.3389/fphar.2023.1340401/full

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10806212/pdf/fphar-14-1340401.pdf

repositoryhttps://doaj.org/article/718681384446464b8a8e9a4e6d195fa2

Europe_PMChttps://europepmc.org/articles/PMC10806212

Fields of Study

0301 basic medicine03 medical and health sciences0302 clinical medicine

Keywords

ResistanceMetastatic Colorectal CancerTyrosine Kinase InhibitorsAnti-egfrAbc Drug TransportersAnti-metPharmacologyTherapeutics. PharmacologyRM1-950

Sustainable Development Goals

SDG 3: 3. Good health